Guilin Sanjin Pharmaceutical Dividends and Buybacks
Dividend criteria checks 5/6
Guilin Sanjin Pharmaceutical is a dividend paying company with a current yield of 4.12% that is well covered by earnings.
Key information
4.1%
Dividend yield
-0.001%
Buyback Yield
| Total Shareholder Yield | 4.1% |
| Future Dividend Yield | 0% |
| Dividend Growth | 6.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.600 |
| Payout ratio | 43% |
Recent dividend and buyback updates
Recent updates
Investors Don't See Light At End Of Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Tunnel
Oct 28
Guilin Sanjin Pharmaceutical's (SZSE:002275) Anemic Earnings Might Be Worse Than You Think
Sep 04Guilin Sanjin Pharmaceutical (SZSE:002275) Is Due To Pay A Dividend Of CN¥0.30
May 23Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Subdued P/E Might Signal An Opportunity
May 22Does Guilin Sanjin Pharmaceutical (SZSE:002275) Deserve A Spot On Your Watchlist?
Apr 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 002275's dividend payments have been volatile in the past 10 years.
Growing Dividend: 002275's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Guilin Sanjin Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (002275) | 4.1% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (002275) (up to 3 years) | 0% |
Notable Dividend: 002275's dividend (4.12%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).
High Dividend: 002275's dividend (4.12%) is in the top 25% of dividend payers in the CN market (2.08%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (43.4%), 002275's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (72.5%), 002275's dividend payments are covered by cash flows.